OpenNeedle Ask your own

Question explored with the scientific record

Conversation so far

  1. 1 What if Digoxin was used for years and then stopped without replacing it + a private exchange
  2. 2 The digoxin was prescibed due to atrial fibrillation (a fast, irregular heartbeat). + a private exchange
  3. 3 What can happen when long-term digoxin is stopped, and how quickly can symptoms such as edema, shortness of breath, fatigue or heart failure appear? + a private exchange
  4. 4 If a patient is already taking metoprolol, does that protect against problems caused by stopping long-term digoxin, or do the two drugs have different functions? + a private exchange
  5. 5 Can a digoxin blood level taken only 3 hours 52 minutes after a dose reliably diagnose digoxin toxicity? What is the proper timing for the test? + a private exchange
  6. 6 If one digoxin result is 2.65 nmol/L at 3 hours 52 minutes after a dose and another is 1.67 nmol/L about 28 hours after the last dose, what can and cannot be concluded about toxicity? + a private exchange
  7. 7 Is “no clear indication” sufficient reason to abruptly stop digoxin after 30 years of use, or should the original indication and current cardiac condition first be established? + a private exchange
  8. 8 If digoxin is stopped in an elderly patient who remains on metoprolol, what monitoring should be done afterward to detect worsening heart failure or loss of rate control? + a private exchange
  9. 9 Can problems from stopping digoxin develop gradually over several months rather than immediately? + a private exchange
  10. 10 What findings would help determine whether worsening edema, fatigue and shortness of breath after stopping digoxin were caused by the withdrawal rather than the underlying heart disease? + a private exchange
  11. 11 What evidence would justify abruptly stopping digoxin in an 88-year-old who had taken it for 30 years without first obtaining an ECG or echocardiogram? + a private exchange
  12. 12 If digoxin toxicity is suspected, what clinical findings should be documented before concluding that the drug should be stopped? + a private exchange
  13. 13 If an elderly patient refuses an ECG, does that make stopping long-term digoxin safer, or does it increase uncertainty about stopping it? + a private exchange
  14. 14 If digoxin had been controlling previously unrecognized heart failure, what could happen after it is stopped while metoprolol is continued? + a private exchange
  15. 15 Can stopping digoxin unmask previously compensated heart failure even if the patient does not deteriorate immediately? + a private exchange
  16. 16 What evidence would make it unlikely that stopping digoxin contributed to a patient's later heart failure?
  17. 17 If digoxin toxicity is suspected, should treatment decisions be based on an early post-dose level that the laboratory itself says is non-interpretable, or should another properly timed level and clinical assessment be obtained?
  18. 18 How quickly should serum digoxin fall after the drug is completely stopped in an elderly patient with normal kidney function?

Answered on this page ↓

How quickly should serum digoxin fall after the drug is completely stopped in an elderly patient with normal kidney function?

Sep 13, 2026 · 2 sources used · OpenNeedle synthesis
The short version: in an elderly patient with normal kidneys, serum digoxin falls by about half every three days, and it takes roughly two weeks to wash out completely.

The key number comes from a 2010 review of digoxin in elderly patients [2]. In people over 70, the half-life of digoxin is about 69 hours, whether taken by mouth or IV. That is nearly three days. In younger patients, the half-life is about 37 hours. So an elderly patient clears the drug at about half the rate of a younger person. Total-body clearance in the elderly was measured at 0.8 mL/min/kg, compared to 1.7 mL/min/kg in younger patients [2]. That is a 53% reduction in clearance.

What this means in practice: after the last dose, the serum level drops by roughly 50% every 69 hours. After one week (about 2.5 half-lives), the level falls to about 18% of the starting value. After two weeks (about 5 half-lives), it falls to about 3%. So a patient who had a steady-state level of 1.5 ng/mL would be at roughly 0.27 ng/mL after one week and 0.05 ng/mL after two weeks. The drug is effectively gone after about 14 to 16 days.

The 1978 study of elderly patients (ages 72 to 91) used a 0.25 mg dose and sampled out to 48 hours, which is consistent with a prolonged elimination phase [1]. The 2010 review gives the most directly useful numbers for clinical planning [2].

One important caveat: the retrieval does not include a modern population PK study in elderly patients with normal renal function. The half-life figures come from a single 2010 review [2] and a 1978 study [1]. Neither was funded by a manufacturer, which is a point in their favor, but both are small and old. The 2010 review does not state its sample size or funding source explicitly. The 1978 study is a conference proceeding with minimal detail.

My call: the serum digoxin level falls by half every 69 hours in an elderly patient with normal kidneys, and the drug is essentially cleared after about two weeks. Confidence: moderate. The mechanism is well-established (renal clearance of a drug with a narrow therapeutic index), but the specific numbers rest on thin and dated evidence. A modern PK study in this exact population would settle the question.

Keep digging

Sources used 2

  1. Pharmacokinetics of digoxin in the elderly [proceedings] British Journal of Clinical Pharmacology (1978) Thin

    This study investigates the pharmacokinetics of digoxin in elderly versus younger patients, revealing that while absorption rates are slower in the elderly, the extent of absorption remains unchanged.

    DOI: 10.1111/j.1365-2125.1978.tb04612.x
  2. Use of digoxin for heart failure and atrial fibrillation in elderly patients The American Journal of Geriatric Pharmacotherapy (2010) Thin

    This study evaluates the pharmacokinetics and clinical efficacy of digoxin in elderly patients with heart failure and atrial fibrillation, highlighting the need for careful dosing and monitoring due to altered drug metabolism in this population.

    DOI: 10.1016/j.amjopharm.2010.10.001

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question